I'm a Sponsor
With over 20 years of experience, we know our stuff.Let us prove it to you!
Our network of fully-owned and integrated research sites provides Phase I-IV clinical trial services for people living with almost any primary health condition, with specialty focus given to diabetes, obesity, metabolic and cardiovascular diseases.
Principle Investigators at each site follow a uniform set of SOPs that follow all ICH, GCP, and Health Canada Division 5 guidelines. Additionally, internal training, fellowship, and certifications are also provided.
We pride ourselves on being global leaders in clinical trial enrollment, providing the capability and capacity to enroll all of Canada’s patient allocation within our network. Because of this, we have established an internal quality assurance and quality control program with successful FDA, Health Canada, and sponsor audits every year.

- 20 sites across 3 provinces and still growing! • Over 2000 clinical trials conducted to date
- Network of 80 Family Physicians & 75 Specialists and still growing!
- Phase I – 12 bed clinical pharmacology unit in Toronto, ON
- Comprehensive patient database of 500,000+ patients with additional 50,000 new patients added each year
- Global leaders in enrollment - 33 first patient first visit (FPFV) for Canada since 2013.
- Over 4000 patient randomizations since 2013
- IQVIA’s 1st Prime Site in Canada (2020)
- Proud Member of VaxCorps Premier Vaccine Site Consortium
- Alliance Partner of hyperCORE International – Centers of Research Excellence
- Part of Sanofi’s “Diabetes Centers of Excellence” Network
- Canadian Association of Independent Clinical Research (CAICR) Membership
- Society for Clinical Research Sites (SCRS) Membership
Services
WHAT WE PROVIDE AS A CENTRALIZED RESEARCH NETWORK
- Uniform SOPs across all 20 sites
- CTA / Budget with 5-day average turnaround
- Regulatory Affairs with Start-Up Specialists
- Recruitment & Marketing Teams
- In-house QA / QC / Training Teams
- Clinical Data Management
- Protocol & Clinical Report Writers
- Independent Clinical Research Associates
- Local Laboratory – Safety & Bioanalytical
PHASE I-IV RESEARCH CAPABILITIES
PHASE I (Clinical Pharmacology Unit in Toronto, ON)
- 12 Unit Metabolic Bed Clinic
- Glucose Clamping
- Metabolic Kitchen
- Access to Primary Care Patients
PHASE II – III
- 20 sites across Canada
- Access to 80 GP’s and 75 Specialists with focus in Endocrine Disorders
- Canada’s Largest Diabetes & Obesity Patient Registries
- Comprehensive patient database of 500,000+ patients with additional 50,000 new patients added each year
PHASE IV
- Post- Marketing Analysis
- Registry Analysis
- Compliance Programs
In over 20 years, our clinical trial experience has grown to include over 50 different therapeutic areas, with over 2000 studies completed at our sites across Canada! Our current research specialties include:
- Cannabis & Psychedelics
- Cardiology
- Dermatology
- Devices/Diagnostics
- Endocrinology
- Gastroenterology
- Gerontology
- Gynecology
- Hepatology
- Immunology
- Men’s Health
- Nephrology
- Neurology
- Nutrition
- Ophthalmology
- Pain Management
- Pediatrics
- Podiatry
- Psychiatry
- Rheumatology
- Pulmonology
- Smoking Cessation
- Urology
- Women’s Health
- SCOPE – March 2-4, 2021
- MAGI – May 3-6, 2021
- World Vaccine Congress – May 4-6, 2021
- ATTD Diabetes – June 2-5, 2021
- ADA – June 25-29, 2021
- DIA 2021 – June 27-July 1, 2021
- World Vaccine Congress Europe – Sept 19-21, 2021
- EASD Diabetes – Sept 27-Oct 1, 2021
- 2021 Global Site Solutions Summit/SCRS – Oct 1-3, 2021
- Canadians Diabetes Association – Nov 24-26, 2021
- World Vaccine West – Nov 30-Dec 2, 2021
Meet our Principal Investigators
As we have grown, sohas our PI network.
With a team of over 50 medical professionals, our PIs come to Centricity Research from multiple therapeutic areas and backgrounds
With this knowledge
They bring their varied experiences and collectively help improve the lives of people through clinical research.